文献速递胃肠外科

完整结肠系膜切除术治疗右半结肠癌的系统评价与GRADE评估

A systematic review, meta-analysis and GRADE assessment of the evidence on complete mesocolic excision for right-sided colon cancer with SAGES and ESCP participation.
PubMed 文献 · Surg Endosc · 2025-05-05

该系统评价与meta分析由欧洲内镜外科协会资助,比较完整结肠系膜切除术(CME)与标准右半结肠切除术的肿瘤学结局。

要点

  • CME与标准右半结肠切除术在30天死亡率、主要围术期并发症及大出血方面无差异。
  • CME组总生存期(HR=0.67,95%CI 0.48-0.93)和无病生存期(HR=0.78,95%CI 0.63-0.96)优于标准手术,但证据确定性低。
  • 证据确定性低主要因观察性研究偏倚风险高,未来需高质量随机试验证实并标准化手术技术。

核心结论

  • 对于右半结肠癌,完整结肠系膜切除术可能较标准右半结肠切除术提供生存获益,但证据确定性低。

主要发现

  • CME与标准结肠切除术在30天死亡率、主要围术期并发症或大出血方面无差异。
  • CME组总生存期改善(HR=0.67,95%CI 0.48-0.93,低证据确定性)。
  • CME组无病生存期改善(HR=0.78,95%CI 0.63-0.96,低证据确定性)。

临床怎么用

  • CME可作为右半结肠癌的一种手术选择,但需权衡低确定性证据并个体化决策。

局限性

  • 证据确定性低,主要因观察性研究占主导且偏倚风险高。
  • 未来需高质量随机试验确认 findings 并标准化手术技术以减少异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Complete mesocolic excision (CME) is a surgical approach for right-sided colon cancer, involving the resection of the primary tumour along with an intact mesocolon, central vascular ligation, and exposure of the superior mesenteric vein. It has been postulated to improve oncologic outcomes such as disease-free survival and reduce local recurrence compared to standard right colectomy. However, the clinical benefits are still debated. OBJECTIVE: This systematic review and meta-analysis, sponsored by the European Association for Endoscopic Surgery, aims to compare the oncologic outcomes of CME with standard right colectomy for right-sided colon cancer, with the ultimate objective to inform clinical practice recommendations. METHODS: We followed the PRISMA 2020 reporting standards. A comprehensive literature search was conducted to identify relevant studies published from 2008 onwards, focusing on randomised trials and matched cohort studies comparing CME with standard right hemicolectomy. The GRADE methodology was used to assess the certainty of evidence, and minimal important differences were calculated to inform clinical relevance. RESULTS: Thirteen studies, amongst which three randomised trials, were included. No difference was found between CME and standard colectomy in terms of 30-day mortality, major peri-operative morbidity, or major blood loss. However, patients who underwent CME showed improved overall survival (HR = 0.67, 95%CI [0.48 - 0.93], low certainty of evidence) and disease-free survival (HR = 0.78, 95% CI [0.63 - 0.96], low certainty of evidence) compared to those who underwent standard colectomy, though certainty of the evidence was low due to the high risk of bias in the observational studies. CONCLUSION: Complete mesocolic excision may offer survival benefits over standard right colectomy for right-sided colon cancer. However, the evidence remains of low certainty, mainly due to the predominance of observational data with significant risk of bias. Future high-quality randomized trials are needed to confirm these findings and standardize surgical techniques to reduce heterogeneity and improve clinical outcomes.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Tzanis AA, Carrano FM, Perivoliotis K, et al. A systematic review, meta-analysis and GRADE assessment of the evidence on complete mesocolic excision for right-sided colon cancer with SAGES and ESCP participation. Surg Endosc. 2025. PMID: 40325243. doi:10.1007/s00464-025-11749-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。